Clinical Differentiation of Axonal vs Demyelinating Neuropathies
Electrodiagnostic (EDX) studies are the definitive method to distinguish between axonal and demyelinating neuropathies and should be included as an integral part of the diagnosis. 1, 2
Primary Diagnostic Approach: Electrodiagnostic Studies
Key EDX Parameters for Demyelinating Neuropathy
Demyelinating neuropathies demonstrate marked conduction velocity slowing at both proximal and distal recording sites, which is the hallmark finding. 3 Specifically look for:
- Marked slowing of motor nerve conduction velocity that remains slow regardless of whether you record from proximal or distal muscles 3
- Prolonged distal motor latencies (DML) 4
- Prolonged F-wave latencies 4
- Conduction block and temporal dispersion - these are critical features to identify 4
- Significant amplitude reduction can occur in demyelinating neuropathies due to temporal dispersion or secondary axonal degeneration, so don't rely on amplitude alone 4, 5
Key EDX Parameters for Axonal Neuropathy
Axonal neuropathies show preferential conduction velocity slowing when recording from distal muscles, but relatively preserved conduction velocity when recording from proximal muscles. 3 Specifically look for:
- Reduced SNAP and CMAP amplitudes as the primary finding 4
- Conduction velocity slowing that is more pronounced distally - this occurs due to selective loss of large, fast-conducting fibers 4, 3
- Relatively preserved conduction velocity proximally when recording from proximal muscles through the same nerve segment 3
- Inverse linear correlation between CMAP amplitude and DML 4
Critical Pitfall to Avoid
Do not rely solely on conduction velocity slowing or amplitude reduction to make the distinction. 4 When CMAP amplitudes are markedly reduced in either condition, conduction velocity may be slowed, making differentiation difficult. The key discriminator is comparing the same nerve segment recorded from proximal versus distal muscles - this provides reliable differentiation even when amplitudes are low. 3
Advanced Diagnostic Techniques (When EDX is Equivocal)
Nerve Excitability Testing
Recovery cycle parameters can distinguish demyelinating from axonal pathology in early disease when conventional nerve conduction studies are ambiguous. 6 Specifically:
- Prolonged relative refractory period suggests axonal pathology (AMSAN: 4.40 ms vs AIDP: 3.09 ms) 6
- Reduced superexcitability indicates axonal involvement (-6.80% in AMSAN vs -26.48% in AIDP) 6
- Subtle changes in threshold electrotonus and strength-duration time constant may be present but are less discriminatory 6
Nerve Ultrasound
Increased nerve cross-sectional area (CSA) measurements help detect demyelinating neuropathies. 7, 8 Look for:
- Significantly greater median nerve thickness in demyelinating neuropathies (sensitivity 57.1%, specificity 92.9% vs axonal) 8
- Systematic CSA measurements at multiple nerve sites provide additional diagnostic cues alongside EDX studies 7
- This is an adjunctive tool, not a replacement for EDX 7, 8
Modern Classification Framework
The traditional dichotomous axonal/demyelinating classification has limitations, particularly for autoimmune neuropathies. 9 Consider that:
- Autoimmune neuropathies targeting nodal region molecules can show electrophysiological demyelinating features without pathological demyelination 9
- Acute neuropathies with antiganglioside antibodies (traditionally classified as axonal) may present with reversible conduction failure and prompt recovery due to nodal dysfunction 9
- Classification based on involved domains of myelinated fibers and molecular targets provides better systematization for autoimmune cases 9
Clinical Context Considerations
Secondary axonal degeneration commonly occurs in chronic demyelinating neuropathies and correlates with clinical deficits and long-lasting disability. 5 This means: